Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
9.41M
-
Shares change
-
-104K
-
Total reported value, excl. options
-
$74.9M
-
Value change
-
-$1.12M
-
Put/Call ratio
-
4.17
-
Number of buys
-
20
-
Number of sells
-
-12
-
Price
-
$7.96
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q3 2024
50 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q3 2024.
Profound Medical Corp. - Common Shares (PROF) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.41M shares
of 29.9M outstanding shares and own 31.48% of the company stock.
Largest 10 shareholders include FIL Ltd (1.54M shares), GAGNON SECURITIES LLC (1.47M shares), LETKO, BROSSEAU & ASSOCIATES INC (1.2M shares), Raymond James Financial Services Advisors, Inc. (760K shares), Timelo Investment Management Inc. (752K shares), Gagnon Advisors, LLC (747K shares), ROYCE & ASSOCIATES LP (569K shares), Rosalind Advisors, Inc. (486K shares), Royal Bank of Canada (401K shares), and ARDSLEY ADVISORY PARTNERS LP (275K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.